2026 NPPES data Research Study Specialist NPI 1063746014 MD
Verify on CMS →

DARO LARGOZA, MD

Research Study Specialist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
62
Medicare Part D claims · 18 beneficiaries · Research Study Specialist avg: 601
Industry payments
$108.8
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: DARO LARGOZA, MD is a Research Study Specialist ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 62 claims across 18 beneficiaries . Industry payments of $108.8 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: DARO LARGOZA, MD filed 62 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

DARO LARGOZA, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 09/23/2009

NPI 1063746014

Primary specialty

Research Study Specialist

Rare

472 US NPIs in this specialty

Medicare Part D claims

62 90% vs specialty avg

2023 prescription claims

Specialty avg: 601

Specialty distribution in New York

How Research Study Specialist compares to other specialties among New York providers

New York providers

Research Study Specialist share within New York

1. Research Study Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Research Study Specialist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Research Study Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Research Study Specialist ABMS/AOA estimate

Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DARO LARGOZA, MD is a Research Study Specialist provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1063746014. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DARO LARGOZA, MD appears in the CMS NPPES registry as a Research Study Specialist provider holding MD credentials at 50 WEST 34TH. ST., NEW YORK, NY, 10001, with a listed phone of (347) 526-1810. NPI 1063746014 was issued on 09/23/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LARGOZA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 62 prescription claims written by this provider, covering 18 Medicare beneficiaries and totaling roughly $195 in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Research Study Specialist is a narrow specialty nationwide, with 472 enrolled providers across 41 states and an average of 601 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

50 WEST 34TH. ST.
NEW YORK, NY 10001

Provider Details

NPI 1063746014
Specialty Research Study Specialist
Credentials MD
Gender Male
NPI Issued 09/23/2009

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DARO LARGOZA, MD. Source: openpaymentsdata.cms.gov.

Total received

$109

Largest payer

Neurocrine Biosciences, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DARO LARGOZA, MD. To verify DARO LARGOZA, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

62
Total Claims
$195
Total Drug Cost
18
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
62
Total Day Supply
397
Generic Drug Cost
$186

Patient Demographics

Average Patient Age
54.4 years
Avg HCC Risk Score
1.42

Research Study Specialist Overview

How DARO LARGOZA, MD fits within the Research Study Specialist landscape nationally.

472
Research Study Specialist Providers in US
41
States with Research Study Specialist
601
Avg Claims per Provider

DARO LARGOZA, MD's 62 claims are below the specialty average of 601.

Nearby Research Study Specialist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as LARGOZA.

Compare Research Study Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is DARO LARGOZA, MD's specialty?
DARO LARGOZA, MD specializes in Research Study Specialist and practices in NEW YORK, New York. Credentials: MD.
How much does DARO LARGOZA, MD prescribe under Medicare Part D?
In 2023, DARO LARGOZA, MD wrote 62 Medicare Part D claims totaling $195 in drug costs for 18 beneficiaries.
Where is DARO LARGOZA, MD located?
DARO LARGOZA, MD is located at 50 WEST 34TH. ST., NEW YORK, NY, 10001. Phone: (347) 526-1810.
What is DARO LARGOZA, MD's NPI number?
DARO LARGOZA, MD's National Provider Identifier (NPI) is 1063746014, issued on 09/23/2009.
How many Research Study Specialist providers are there in the US?
There are 472 Research Study Specialist providers across 41 states in the US. The average Research Study Specialist provider writes 601 Medicare Part D claims per year.
Does DARO LARGOZA, MD accept Medicare?
DARO LARGOZA, MD appears in CMS Medicare data with 62 Part D claims and 18 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DARO LARGOZA, MD's credentials?
DARO LARGOZA, MD's NPI is 1063746014 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology